Literature DB >> 497834

The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions.

I Walaas, F Fonnum.   

Abstract

The distribution of choline acetyltransferase (ChAT) and glutamate decarboxylase (GAD), and the histochemical reaction for acetylcholinesterase have been studied in the basal forebrain and globus pallidus of unoperated rats and in rats with an electrolytic lesion of the nucleus accumbens. ChAT was highly concentrated in the substriatal region, the neostriatum and the lateral part of the rostral substantia innominata. The strongest intensity of staining for acetylcholinesterase was found in the substriatal grey and the neostriatum. Very high GAD activity was found in the substantia innominata, being even slightly higher than that in the pars reticulata of the substantia nigra. The lateral preoptic area, the bed nucleus of the stria terminalis and the globus pallidus also showed high activity of GAD. After lesions of the nucleus accumbens the activity of GAD decreased significantly in the substantia innominata and in a restricted part of the rostroventral globus pallidus, but not in the other regions studied. ChAT activity and acetylcholinesterase staining were unaffected in all regions. The results indicate that a dense GABAergic projection originates in the nucleus accumbens and terminates in the rostral substantia innominata and rostroventral part of the globus pallidus. The study gives neurochemical support to the suggestion that nucleus accumbens may be regarded as a ventral part of the neostriatum and that the rostral substantia innominata may be regarded as a ventral part of the globus pallidus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 497834     DOI: 10.1016/0006-8993(79)90783-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Slow phasic and tonic activity of ventral pallidal neurons during cocaine self-administration.

Authors:  David H Root; Anthony T Fabbricatore; Anthony P Pawlak; David J Barker; Sisi Ma; Mark O West
Journal:  Synapse       Date:  2011-11-03       Impact factor: 2.562

Review 2.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

3.  The efferent connections of the lateral septal nucleus in the guinea pig: projections to the diencephalon and brainstem.

Authors:  J F Staiger; F Nürnberger
Journal:  Cell Tissue Res       Date:  1991-06       Impact factor: 5.249

4.  The olfactory tubercle of the cat. II. Immunohistochemical compartmentation.

Authors:  P Wahle; G Meyer
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

Review 5.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 6.  Glutamate, GABA, and CNS disease: a review.

Authors:  J E Walker
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

7.  An investigation of the origin of extracellular GABA in rat nucleus accumbens measured in vivo by microdialysis.

Authors:  S E Smith; T Sharp
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum.

Authors:  K J Page; B J Everitt
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

9.  Opioid and GABA modulation of accumbens-evoked ventral pallidal activity.

Authors:  J J Chrobak; T C Napier
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 10.  Extinction circuits for fear and addiction overlap in prefrontal cortex.

Authors:  Jamie Peters; Peter W Kalivas; Gregory J Quirk
Journal:  Learn Mem       Date:  2009-04-20       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.